Paul L. Foster School of Medicine Receives Accreditation

The school's inaugural class will graduate in May.

The school's inaugural class will graduate in May.

The Paul L. Foster School of Medicine has officially been approved for full accreditation from the Liaison Committee on Medical Education (LCME) for a period of eight years.

The LCME, sponsored by the Association of American Medical Colleges and the American Medical Association, is the nationally recognized accrediting authority for medical education programs leading to a medical degree in the United States and Canada.

“It has been an arduous task moving the accreditation process to a successful outcome, but well worth it. The rewards can be seen everywhere,” said Jose Manuel de la Rosa, M.D., Paul L. Foster School of Medicine founding dean and vice president for health affairs. “It is because of a team effort that our students, our city and the world now have the only fully accredited, four-year medical school on the U.S./Mexico border. We thank the El Paso community for helping make us what we are today a symbol of their hope and pride in our community.”

The accreditation approval process for the Paul L. Foster School of Medicine began in 2008 when the school received provisional accreditation that allowed it to begin recruiting students for its inaugural class of 40 students. That class, the Class of 2013, will graduate in May.

Students at the Paul L. Foster School of Medicine are educated using an innovative approach that includes a clinical presentation curriculum with early clinical experiences.

LCME reviewers gave the school six commendations for strengths in numerous areas including:

  • The focused efforts and progress toward creating an increased educational and academic presence and improving the health of the border region
  • Effective integration, relevancy and reception of year one and two curriculum, organized around and taught through clinical problems and diagnostic algorithms that anchor and relate basic science concepts with clinical skills and behavioral science
  • An effort to integrate its mission into the curriculum through courses and experiences that immerse students in the culture and community of the Texas border region including a required medical Spanish course
  • Taking steps to minimize the educational debt of medical students including maintaining low tuition rates and providing scholarship support
  • The commitment and demonstrated effort of the faculty and administration in achieving excellence in medical education
  • A robust faculty development process and mentoring system aimed at enhancing the skills of junior faculty

Related Stories

Molecular Pathology Preceptorship: Unmatched Value and Experience

Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.

Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing

Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.

TTUHSC School of Nursing to Celebrate New YWCA Location

Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.

Recent Stories

Health

Measles Outbreak: What to Know From The Future of Health

Kelissa Huse, an assistant professor and laboratory manager in the Molecular Pathology Program at TTUHSC, spoke about measles, the outbreak and what West Texans needs to know about the disease.

Education

Santos Named Department of Surgery Chair for TTUHSC School of Medicine in Lubbock

As the new Department of Surgery chair for the School of Medicine in Lubbock, Ariel Santos, M.D., M.P.H., seeks to elevate TTUHSC’s role as the Hub of Surgery for West Texas.

Health

Covenant Health Brings Kidney Transplant Surgery Back to West Texas

The Kidney Transplant Program at Covenant Medical Center will provide life-changing opportunities for patients suffering from end-stage renal disease (ESRD) and chronic kidney conditions.